Oruka Therapeutics, Inc. ($ORKA)
Filing Information
| Accession Number | 0000907654-26-000106 |
|---|---|
| Form Type | 4 |
| Filing Date | Oct 13, 2026 |
| Document | View SEC Filing |
Transactions
8
Total Shares
29,997
Total Value
$962,791.99
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Senior Vice President, Finance | Common Stock | โ | Oct 12, 2026 | Exercise/Conversion | 8,541 | $12.50 | $106,762.50 | 22,760 | Direct | โ | View Details | |
Senior Vice President, Finance | Common Stock | โ | Oct 12, 2026 | Exercise/Conversion | 1,458 | $34.39 | $50,140.62 | 24,218 | Direct | โ | View Details | |
Senior Vice President, Finance | Common Stock | โ | Oct 12, 2026 | Sale | 5,741 | $80.03 | $459,453.38 | 18,477 | Direct | โ | View Details | |
Senior Vice President, Finance | Common Stock | โ | Oct 12, 2026 | Sale | 2,100 | $80.76 | $169,596.21 | 16,377 | Direct | โ | View Details | |
Senior Vice President, Finance | Common Stock | โ | Oct 12, 2026 | Sale | 1,958 | $81.86 | $160,272.29 | 14,419 | Direct | โ | View Details | |
Senior Vice President, Finance | Common Stock | โ | Oct 12, 2026 | Sale | 200 | $82.83 | $16,567.00 | 14,219 | Direct | โ | View Details | |
Senior Vice President, Finance | Employee Stock Option (right to buy) | Derivative | Oct 12, 2026 | Exercise/Conversion | 8,541 | $0.00 | $0.00 | 76,376 | Direct | โ | View Details | |
Senior Vice President, Finance | Employee Stock Option (right to buy) | Derivative | Oct 12, 2026 | Exercise/Conversion | 1,458 | $0.00 | $0.00 | 56,875 | Direct | โ | View Details |